Alpha Tau Medical Ltd.
DRTS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $8 | $7 | $7 | $8 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $2 | $3 | $2 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | -$59 | $0 | $0 | $0 |
| Operating Expenses | -$49 | $10 | $9 | $10 |
| Operating Income | $49 | -$10 | -$9 | -$10 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$60 | -$0 | $1 | $1 |
| Pre-Tax Income | -$12 | -$10 | -$9 | -$9 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$12 | -$10 | -$9 | -$9 |
| % Margin | – | – | – | – |
| EPS | -0.14 | -0.13 | -0.12 | -0.14 |
| % Growth | -7.7% | -8.3% | 14.3% | – |
| EPS Diluted | -0.14 | -0.13 | -0.12 | -0.14 |
| Weighted Avg Shares Out | 84 | 80 | 70 | 70 |
| Weighted Avg Shares Out Dil | 85 | 80 | 70 | 70 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$10 | -$9 | -$9 | -$5 |
| % Margin | – | – | – | – |